Answers are grounded in this paper and cite their sources.
This study aimed to assess the effectiveness and safety of triamcinolone acetonide administered through suprachoroidal space in subjects with diabetic macular edema. A prospective study was conducted in the Department of Ophthalmology, Nishtar Hospital, Multan, from April 2022- April 2023. A total of 40 patients with diabetic macular edema by optical coherence tomography were included in the study. During surgery, 4mg/100 µL triamcinolone acetonide was injected. The patients were followed up for a week to evaluate post-injection adverse effects. In addition,It was noted that the injection improved the VA significantly. After 6 months of follow-up, the VA was 0.69 ± 0.1 (p<0.001). Significant improvement was seen in optical coherence tomography measurement; after 6 months, it was reduced to 265.6 ± 39.1 µm (p<0.001). No significant difference was noted in intraocular pressure from baseline to follow-up. Based on the results, administering triamcinolone acetonide through suprachoroidal space in diabetic macular edema is effective without any adverse effects.
No takes yet. Share an insight, caveat, or question.
FATIMA et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: